Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Cancer immunology.

Finn OJ.

N Engl J Med. 2008 Jun 19;358(25):2704-15. doi: 10.1056/NEJMra072739. Review. No abstract available.

PMID:
18565863
2.

Tumor immunology top 10 list.

Finn OJ.

Immunol Rev. 2008 Apr;222:5-8. doi: 10.1111/j.1600-065X.2008.00623.x. No abstract available.

PMID:
18363991
3.

Active Immunotherapy of Cancer.

Chodon T, Koya RC, Odunsi K.

Immunol Invest. 2015;44(8):817-36. doi: 10.3109/08820139.2015.1096684. Review.

PMID:
26575466
4.

Promising immunotherapy technique.

Fillon M.

J Natl Cancer Inst. 2012 Oct 17;104(20):1528-9. doi: 10.1093/jnci/djs449. Epub 2012 Oct 8. No abstract available.

PMID:
23044382
5.

From therapeutic monoclonal antibodies to therapeutic vaccines for cancer.

Berinstein NL.

Hum Vaccin. 2009 Jun;5(6):364-7. No abstract available.

PMID:
19694082
6.

Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.

Baxevanis CN, Perez SA, Papamichail M.

Cancer Immunol Immunother. 2009 Mar;58(3):317-24. doi: 10.1007/s00262-008-0576-4. Epub 2008 Aug 15. Review.

PMID:
18704409
7.

Cancer immunotherapy comes of age.

Mellman I, Coukos G, Dranoff G.

Nature. 2011 Dec 21;480(7378):480-9. doi: 10.1038/nature10673. Review.

8.

Cancer immunotherapy--the endgame begins.

Weiner LM.

N Engl J Med. 2008 Jun 19;358(25):2664-5. doi: 10.1056/NEJMp0803663. No abstract available.

9.

Cancer immunotherapy: a treatment for the masses.

Blattman JN, Greenberg PD.

Science. 2004 Jul 9;305(5681):200-5. Review.

PMID:
15247469
10.

[The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases].

Alfaro C, Murillo O, Tirapu I, Azpilicueta A, Huarte E, Arina A, Arribillaga L, Pérez-Gracia JL, Bendandi M, Prieto J, Lasarte JJ, Melero I.

An Sist Sanit Navar. 2006 Jan-Apr;29(1):77-96. Review. Spanish.

11.

Strategies for immunotherapy of cancer.

Melief CJ, Toes RE, Medema JP, van der Burg SH, Ossendorp F, Offringa R.

Adv Immunol. 2000;75:235-82. Review. No abstract available.

PMID:
10879286
12.

[Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].

Jäger E, Jäger D, Knuth A.

Dtsch Med Wochenschr. 2001 Sep 14;126(37):1011-6. Review. German. No abstract available.

PMID:
11555776
13.

Cancer immunotherapy.

Schuster M, Nechansky A, Kircheis R.

Biotechnol J. 2006 Feb;1(2):138-47. Review.

PMID:
16892244
14.

Monoclonal antibodies: versatile platforms for cancer immunotherapy.

Weiner LM, Surana R, Wang S.

Nat Rev Immunol. 2010 May;10(5):317-27. doi: 10.1038/nri2744. Review.

15.

Antibody-targeted immunotherapy for treatment of malignancy.

White CA, Weaver RL, Grillo-López AJ.

Annu Rev Med. 2001;52:125-45. Review. Erratum in: Annu Rev Med 2002;53:xi.

PMID:
11160771
16.

[Immunological tumor therapy].

Dietrich K, Theobald M.

Internist (Berl). 2015 Aug;56(8):907-16; quiz 917. doi: 10.1007/s00108-015-3744-6. Review. German.

PMID:
26187335
17.

Immunotherapy's cancer remit widens.

Ledford H.

Nature. 2013 May 30;497(7451):544. doi: 10.1038/497544a. No abstract available.

PMID:
23719439
18.

Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer.

Ramakrishnan R, Gabrilovich DI.

Cancer Immunol Immunother. 2011 Mar;60(3):419-23. doi: 10.1007/s00262-010-0930-1. Epub 2010 Oct 26. Review.

PMID:
20976448
19.

CTLA-4 blockade: autoimmunity as treatment.

Kapadia D, Fong L.

J Clin Oncol. 2005 Dec 10;23(35):8926-8. Epub 2005 Oct 3. No abstract available.

PMID:
16204008
20.

Radiation and immunotherapy: a synergistic combination.

Kalbasi A, June CH, Haas N, Vapiwala N.

J Clin Invest. 2013 Jul;123(7):2756-63. doi: 10.1172/JCI69219. Epub 2013 Jul 1.

Supplemental Content

Support Center